Research Article

Virus-like particles of the Foot-and-Mouth Disease Virus in Saccharomyces cerevisiae induce an immune response in a mouse model

Ngoc My Tieu Le, Jeesun Chun, Yo-Han Ko, Geonmin Kim, Nguyen Ngoc Luong, Dae-Hyuk Kim*
Author Information & Copyright ▼
1Jeonbuk National University, Jeonju-si 54896, Korea.
2Hue University, Hue , Viet Nam.
*Corresponding Author: Dae-Hyuk Kim, Phone: +82632703440. E-mail: dhkim@jbnu.ac.kr.

© Copyright 2026 Korean Society of Animal Science and Technology. This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: Aug 25, 2026; Revised: Oct 08, 2026; Accepted: Nov 07, 2026

Published Online: Nov 13, 2026

Abstract

Virus-like particle (VLP)–based vaccines represent an innovative strategy that mimics the structural properties of native viruses while lacking infectious genetic material, thereby combining safety with potent immunogenicity. This platform is increasingly recognized as one of the most promising approaches to induce effective, long-lasting protective immunity. Foot-and-mouth disease virus (FMDV), a member of the Picornaviridae family, is the causative agent of a highly contagious vesicular disease affecting cloven-hoofed animals and poses significant economic threats worldwide. Previously, we demonstrated that FMDV VLPs were successfully expressed, processed, and assembled into empty virus particles in Saccharomyces cerevisiae, maintaining the stability and assembly efficiency after 3 days at 30 °C. The results indicate that the yeast-based platform provides a favorable environment for proper folding and self-assembly of capsid proteins into structurally intact VLPs. Furthermore, a two-step purification protocol comprising size-exclusion chromatography followed by sucrose density gradient ultracentrifugation effectively removed host cell proteins and other contaminants, yielding highly purified and structurally homogeneous VLP preparations. In the current study, we further enhanced the stability and assembly efficiency of FMDV VLPs by optimizing culture conditions in the yeast expression system. Moreover, initial oral administration in a mouse model induced robust systemic and mucosal immune responses, with generated antibodies cross-reacting with bacterially expressed VP1, confirming the preservation of key antigenic determinants. The immunogenicity of purified VLPs was further evaluated by parenteral administration, and the induced antibodies recognized bacterially expressed VP1, indicating that the purified VLPs preserved antigenic determinants. Therefore, we have demonstrated the potent immunogenicity of these optimized VLPs in mice following both oral and parenteral administration, thereby inducing systemic and mucosal immune responses. We establish a promising yeast-based VLP platform for scalable FMDV vaccine development.

Keywords: Foot-and-mouth disease virus; virus-like particle; Saccharomyces cerevisiae; oral immunization; immunogenicity; mucosal immunity


Revised Publication Charge


(Effective for articles submitted beginning January 1, 2026)

The publication charge is 1,500,000 Korean Won per article for members of the Korean Society of Animal Science and Technology (KSAST), and 2,000,000 Korean Won for non-members. First and corresponding authors are required to pay the annual membership fee.

The publication charge for a corresponding author outside Korea is 1,500 US dollars per article.


I don't want to open this window for a week.